Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)
for Amyotrophic Lateral Sclerosis
Sponsor: Q Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT02478450·Phase 1, Phase 2·Not Yet Recruiting·Listed Jun 2015